Close
ACHEMA MIDDLE EAST 2026

Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has...

$850 Million USD investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity

FUJIFILM Corporation announced a ¥90 Billion Yen (~$850 Million USD) investment package to accelerate the growth of its core Bio CDMO subsidiary, FUJIFILM Diosynth...

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

Waters Corporation announced an expansion of its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology...

Siemens and BioNTech expand their collaboration for global vaccine production

German biotechnology company BioNTech SE and Siemens intend to expand their strategic cooperation. The companies plan to intensify their collaboration for the rapid expansion...

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Fujitsu Japan Limited announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of...

Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials

Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...